Bilateral intermediate uveitis in a healthy teenager with the multisystem inflammatory syndrome in children secondary to COVID-19 infection

J Med Virol. 2022 Apr;94(4):1269-1271. doi: 10.1002/jmv.27521. Epub 2021 Dec 17.

Authors

Alex Y C Sim¹, Ainal A Naffi¹, Tang S Fai¹, Najma Kori², Wan A W Zaidi², Petrick Periyasamy², Norshamsiah Md Din¹, Mushawiahti Mustapha¹, Ayesha Mohd Zain¹

Affiliations

¹ Department of Ophthalmology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
² Infectious Disease Unit, Department of Internal Medicine, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.

PMID: 34897747
DOI: 10.1002/jmv.27521

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adolescent
COVID-19 / complications*
COVID-19 / diagnosis
COVID-19 / therapy
Dexamethasone / therapeutic use
Humans
Male
SARS-CoV-2 / isolation & purification
Systemic Inflammatory Response Syndrome / complications*
Systemic Inflammatory Response Syndrome / diagnosis
Systemic Inflammatory Response Syndrome / therapy
Treatment Outcome
Uveitis, Intermediate / diagnosis
Uveitis, Intermediate / drug therapy
Uveitis, Intermediate / etiology*

Substances

Dexamethasone

Supplementary concepts

pediatric multisystem inflammatory disease, COVID-19 related